Accolade Inc. (ACCD): Price and Financial Metrics

Accolade Inc. (ACCD): $12.68

0.73 (+6.11%)

POWR Rating

Component Grades













Add ACCD to Watchlist
Sign Up

Industry: Internet



in industry


  • ACCD scores best on the Sentiment dimension, with a Sentiment rank ahead of 50.3% of US stocks.
  • The strongest trend for ACCD is in Stability, which has been heading up over the past 178 days.
  • ACCD ranks lowest in Quality; there it ranks in the 13th percentile.

ACCD Stock Summary

  • ACCOLADE INC's stock had its IPO on July 2, 2020, making it an older stock than only 14.21% of US equities in our set.
  • Of note is the ratio of ACCOLADE INC's sales and general administrative expense to its total operating expenses; merely 13.79% of US stocks have a lower such ratio.
  • Over the past twelve months, ACCD has reported earnings growth of 359.12%, putting it ahead of 95.76% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ACCOLADE INC, a group of peers worth examining would be BLND, GGR, GORO, REKR, and AGI.
  • Visit ACCD's SEC page to see the company's official filings. To visit the company's web site, go to

ACCD Valuation Summary

  • In comparison to the median Technology stock, ACCD's price/sales ratio is 0% higher, now standing at 2.4.
  • ACCD's price/earnings ratio has moved up 25.3 over the prior 33 months.

Below are key valuation metrics over time for ACCD.

Stock Date P/S P/B P/E EV/EBIT
ACCD 2023-03-14 2.4 1.8 -1.9 -1.9
ACCD 2023-03-13 2.4 1.8 -1.9 -1.8
ACCD 2023-03-10 2.3 1.7 -1.8 -1.8
ACCD 2023-03-09 2.5 1.8 -1.9 -1.9
ACCD 2023-03-08 2.6 1.9 -2.0 -2.0
ACCD 2023-03-07 2.6 1.9 -2.0 -2.0

ACCD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ACCD has a Quality Grade of D, ranking ahead of 16.91% of graded US stocks.
  • ACCD's asset turnover comes in at 0.297 -- ranking 433rd of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows ACCD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-08-31 0.297 0.433 -2.101
2021-05-31 0.369 0.447 -2.074
2021-02-28 0.512 0.450 2.793
2020-02-28 1.906 0.444 3.310
2020-02-28 1.906 0.444 3.310
2020-02-28 1.906 0.444 3.310

ACCD Price Target

For more insight on analysts targets of ACCD, see our ACCD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $63.00 Average Broker Recommendation 1.18 (Strong Buy)

ACCD Stock Price Chart Interactive Chart >

Price chart for ACCD

ACCD Price/Volume Stats

Current price $12.68 52-week high $19.39
Prev. close $11.95 52-week low $4.61
Day low $11.91 Volume 478,200
Day high $12.91 Avg. volume 716,189
50-day MA $11.31 Dividend yield N/A
200-day MA $10.11 Market Cap 922.94M

Accolade Inc. (ACCD) Company Bio

Accolade, Inc. is an emerging growth company, which engages in the provision of personalized, technology-enabled solutions through a technology platform. It offers Accolade Total Benefits and Accolade Total Care. Accolade Total Benefits focuses on member benefits engagement and Accolade Total Care help guides members to healthcare providers. The company was founded by Thomas K. Spann and J. Michael Cline in 2007 and is headquartered in Seattle, WA.

ACCD Latest News Stream

Event/Time News Detail
Loading, please wait...

ACCD Latest Social Stream

Loading social stream, please wait...

View Full ACCD Social Stream

Latest ACCD News From Around the Web

Below are the latest news stories about ACCOLADE INC that investors may wish to consider to help them evaluate ACCD as an investment opportunity.

Accolade Welcomes Lyra Health to Its Trusted Partner Ecosystem

Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with Personalized Healthcare, has partnered with Lyra Health, a leading provider of global workforce mental health solutions. By adding Lyra to its Trusted Partner Ecosystem, Accolade is building on its commitment to offer best-in-class behavioral health solutions to its customers through both strategic partnerships and in-house capabilities.

Yahoo | March 6, 2023

Should You Investigate Accolade, Inc. (NASDAQ:ACCD) At US$13.30?

Accolade, Inc. ( NASDAQ:ACCD ), might not be a large cap stock, but it received a lot of attention from a substantial...

Yahoo | March 5, 2023

Accolade plans to reduce headcount, downsize office footprint

Last year, Accolade revealed it was losing Philadelphia-based Comcast, its biggest client, at the end of 2022.

Yahoo | March 3, 2023

An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 31% Undervalued

How far off is Accolade, Inc. ( NASDAQ:ACCD ) from its intrinsic value? Using the most recent financial data, we'll...

Yahoo | February 16, 2023

Michael Hilton Joins Accolade Board of Directors

Co-founder of Concur joins Board after serving as the Company’s CIOSEATTLE, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced changes to its Board of Directors. The Company announced today that long-time executive Michael Hilton will step down from his operating role at the Company to join the Board of Directors, replacing Tom Neff, who has served on Accolade’s Board since 2010. “Michael has been instrumental in helping Accolade reshape how healthcare is experienced

Yahoo | February 16, 2023

Read More 'ACCD' Stories Here

ACCD Price Returns

1-mo N/A
3-mo 59.10%
6-mo 7.73%
1-year -25.50%
3-year N/A
5-year N/A
YTD 62.77%
2022 -70.45%
2021 -39.40%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7887 seconds.